Public Health Pioneer Peter Pharoah Dies at 87

Pharoah’s work ended endemic cretinism in a remote region of Papua New Guinea and contributed to the understanding of myriad other perinatal health conditions.

Written byDan Robitzski
| 2 min read
Man in a white shirt and a large backpack stands on a hill overlooking dense forest
Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Peter Pharoah, a public health expert whose clinical work on nutrition during pregnancy was crucial for ending the motor disability endemic cretinism in regions of Papua New Guinea, passed away from dementia at the age of 87 on October 23.

Pharoah was born in 1934 in Ranchi, India, to teachers Phyllis and Oswald Pharoah, the latter of whom passed away when Peter was seven years old. Peter moved to the UK in 1948 to continue his education. He met Margaret McMinn, who he would eventually marry in 1960, while both were training as doctors at St. Mary’s Hospital Medical School in London, according to an obituary penned by his son, University of Cambridge cancer epidemiologist Paul Pharoah, in The Guardian.

After working for the National Health Service (NHS) at various London hospitals from 1958 to 1963, Pharoah began serving as a medical officer in Papa New Guinea, where he would ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • black and white image of young man in sunglasses with trees in background

    Dan is an award-winning journalist based in Los Angeles who joined The Scientist as a reporter and editor in 2021. Ironically, Dan’s undergraduate degree and brief career in neuroscience inspired him to write about research rather than conduct it, culminating in him earning a master’s degree in science journalism from New York University in 2017. In 2018, an Undark feature Dan and colleagues began at NYU on a questionable drug approval decision at the FDA won first place in the student category of the Association of Health Care Journalists' Awards for Excellence in Health Care Journalism. Now, Dan writes and edits stories on all aspects of the life sciences for the online news desk, and he oversees the “The Literature” and “Modus Operandi” sections of the monthly TS Digest and quarterly print magazine. Read more of his work at danrobitzski.com.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies